FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Murray Dallan
(Last) (First) (Middle)
215 FIRST STREET
(Street)
CAMBRIDGE MA 02142
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/24/2024 		3. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Customer Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 21,760
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to buy) 03/03/2018 (1) 03/03/2027 Common Stock 1,710 34.39 D  
Stock Option (Right to buy) 03/05/2019 (1) 03/05/2028 Common Stock 1,861 71.45 D  
Stock Option (Right to buy) 03/03/2018 (1) 03/03/2027 Common Stock 113 34.39 D  
Stock Option (Right to buy) 03/05/2019 (1) 03/05/2028 Common Stock 9,039 71.45 D  
Stock Option (Right to buy) 03/04/2020 (1) 03/04/2029 Common Stock 533 145.48 D  
Stock Option (Right to buy) 03/04/2020 (1) 03/04/2029 Common Stock 429 145.48 D  
Stock Option (Right to buy) 02/28/2021 (1) 02/28/2030 Common Stock 225 114.47 D  
Stock Option (Right to buy) 12/14/2021 (1) 12/14/2030 Common Stock 438 169.54 D  
Stock Option (Right to buy) 03/03/2022 (1) 03/03/2031 Common Stock 1,148 87.11 D  
Stock Option (Right to buy) 03/07/2023 (1) 03/07/2032 Common Stock 1,244 80.42 D  
Stock Option (Right to buy) 03/01/2025 (1) 03/01/2034 Common Stock 777 128.67 D  
Stock Option (Right to buy) 03/06/2024 (1) 03/06/2033 Common Stock 641 155.99 D  
Stock Option (Right to buy) 03/04/2020 (1) 03/04/2029 Common Stock 3,617 145.48 D  
Stock Option (Right to buy) 03/04/2020 (1) 03/04/2029 Common Stock 8,821 145.48 D  
Stock Option (Right to buy) 02/28/2021 (1) 02/28/2030 Common Stock 5,170 114.47 D  
Stock Option (Right to buy) 12/14/2021 (1) 12/14/2030 Common Stock 24,562 169.54 D  
Stock Option (Right to buy) 03/03/2022 (1) 03/03/2031 Common Stock 58,852 87.11 D  
Stock Option (Right to buy) 03/07/2023 (1) 03/07/2032 Common Stock 46,756 80.42 D  
Stock Option (Right to buy) 03/01/2025 (1) 03/01/2034 Common Stock 11,723 128.67 D  
Stock Option (Right to buy) 03/06/2024 (1) 03/06/2033 Common Stock 26,359 155.99 D  
Explanation of Responses:
1. Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.
/s/ Ryan Brown as Attorney-in-Fact for Dallan Murray 05/06/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-24